167 related articles for article (PubMed ID: 36823199)
21. Thrombocytopenia in adult cancer patients receiving cytotoxic chemotherapy: results from a retrospective hospital-based cohort study.
Ten Berg MJ; van den Bemt PM; Shantakumar S; Bennett D; Voest EE; Huisman A; van Solinge WW; Egberts TC
Drug Saf; 2011 Dec; 34(12):1151-60. PubMed ID: 22077503
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy-induced thrombocytopenia in Ewing sarcoma: Implications and potential for romiplostim supportive care.
Merjaneh N; Young J; Mangoli A; Olsen M; Setty B; Lane A; Nagarajan R; Pressey JG; Turpin B
Pediatr Blood Cancer; 2022 Jul; 69(7):e29548. PubMed ID: 34962714
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness analysis of rhTPO and rhIL-11 in the treatment of chemotherapy-induced thrombocytopenia in hematological tumors based on real-world data.
Zhang JJ; Zhao R; Xia F; Li Y; Wang RW; Guan X; Zhu JG; Ma AX
Ann Palliat Med; 2022 Aug; 11(8):2709-2719. PubMed ID: 36064361
[TBL] [Abstract][Full Text] [Related]
24. Treatment of chemotherapy-induced thrombocytopenia in patients with non-hematologic malignancies.
Kuter DJ
Haematologica; 2022 Jun; 107(6):1243-1263. PubMed ID: 35642485
[TBL] [Abstract][Full Text] [Related]
25. Thrombopoietin level predicts response to treatment with romiplostim in chemotherapy-induced thrombocytopenia.
Song AB; Goodarzi K; Karp Leaf R; Kuter DJ; Al-Samkari H
Am J Hematol; 2021 Dec; 96(12):1563-1568. PubMed ID: 34453757
[TBL] [Abstract][Full Text] [Related]
26. Chinese Herbal Medicine (
Qi S; Li X; Dong Q; Lai H; Porter D; Tian S; Hou L; Chen X; Li X; Wang K
J Altern Complement Med; 2019 Jun; 25(6):648-655. PubMed ID: 31090434
[No Abstract] [Full Text] [Related]
27. Romiplostim for management of chemotherapy-induced thrombocytopenia.
Parameswaran R; Lunning M; Mantha S; Devlin S; Hamilton A; Schwartz G; Soff G
Support Care Cancer; 2014 May; 22(5):1217-22. PubMed ID: 24414994
[TBL] [Abstract][Full Text] [Related]
28. Predictive value of baseline plasma D-dimers for chemotherapy- induced thrombocytopenia in patients with stage III colon cancer: a pilot study.
Tanriverdi O
Asian Pac J Cancer Prev; 2013; 14(1):293-7. PubMed ID: 23534740
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of romiplostim in the treatment of chemotherapy induced thrombocytopenia (CIT) in a patient with mantle cell lymphoma.
Demeter J; Istenes I; Fodor A; Paksi M; Dombi P; Valasinyószki E; Csomor J; Matolcsy A; Nagy ZG
Pathol Oncol Res; 2011 Mar; 17(1):141-3. PubMed ID: 20628840
[TBL] [Abstract][Full Text] [Related]
30. Thrombopoietin receptor agonists for chemotherapy-induced thrombocytopenia: a new solution for an old problem.
Al-Samkari H
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):286-295. PubMed ID: 36485134
[TBL] [Abstract][Full Text] [Related]
31. Is there a predictive significance of ABO blood group on chemotherapy-induced thrombocytopenia in patients with stage III colon cancer?
Tanriverdi O
Med Oncol; 2015 Jan; 32(1):384. PubMed ID: 25428389
[TBL] [Abstract][Full Text] [Related]
32. Systematic literature review and meta-analysis on use of Thrombopoietic agents for chemotherapy-induced thrombocytopenia.
Soff GA; Ray-Coquard I; Rivera LJM; Fryzek J; Mullins M; Bylsma LC; Park JK
PLoS One; 2022; 17(6):e0257673. PubMed ID: 35679540
[TBL] [Abstract][Full Text] [Related]
33. [Experience of off-label use of Eltrombopag in the treatment of thrombocytopenia associated with solid tumors].
García Lagunar MH; Cerezuela Fuentes P; Martínez Penella M; Gutiérrez-Meca Maestre DP; García Coronel M; Martínez Ortiz MJ
Farm Hosp; 2015 May; 39(3):157-60. PubMed ID: 26005891
[TBL] [Abstract][Full Text] [Related]
34. Avatrombopag for chemotherapy-induced thrombocytopenia in patients with non-haematological malignancies: an international, randomised, double-blind, placebo-controlled, phase 3 trial.
Al-Samkari H; Kolb-Sielecki J; Safina SZ; Xue X; Jamieson BD
Lancet Haematol; 2022 Mar; 9(3):e179-e189. PubMed ID: 35240074
[TBL] [Abstract][Full Text] [Related]
35. Younger age and previous exposure to radiation therapy are correlated with the severity of chemotherapy-induced thrombocytopenia.
Mkhitaryan S; Danielyan S; Sargsyan L; Hakobyan L; Iskanyan S; Bardakchyan S; Papyan R; Arakelyan J; Sahakyan K; Avagyan T; Tananyan A; Muradyan A; Tamamyan G
Ecancermedicalscience; 2019; 13():906. PubMed ID: 30915164
[TBL] [Abstract][Full Text] [Related]
36. A Nomogram Combining Neutrophil-to-Lymphocyte Ratio and D-Dimer Predicts Chemosensitivity of Oxaliplatin-Based First-Line Chemotherapy in Patients with Unresectable Advanced Gastric Cancer.
Shen H; Wu S; Su R; Chen Y; He Y
Technol Cancer Res Treat; 2022; 21():15330338221112741. PubMed ID: 35880288
[No Abstract] [Full Text] [Related]
37. Chemotherapy induced thrombocytopenia in pediatric oncology.
Tamamyan G; Danielyan S; Lambert MP
Crit Rev Oncol Hematol; 2016 Mar; 99():299-307. PubMed ID: 26811139
[TBL] [Abstract][Full Text] [Related]
38. Risk prediction models based on hematological/body parameters for chemotherapy-induced adverse effects in Chinese colorectal cancer patients.
Li M; Chen J; Deng Y; Yan T; Gu H; Zhou Y; Yao H; Wei H; Chen W
Support Care Cancer; 2021 Dec; 29(12):7931-7947. PubMed ID: 34213641
[TBL] [Abstract][Full Text] [Related]
39. A Case Study Using Papaya Leaf Extract to Reverse Chemotherapy-Induced Thrombocytopenia in a GBM Patient.
Koehler A; Rao R; Rothman Y; Gozal YM; Struve T; Alschuler L; Sengupta S
Integr Cancer Ther; 2022; 21():15347354211068417. PubMed ID: 34984951
[TBL] [Abstract][Full Text] [Related]
40. A nomogram for predicting mortality in patients with COVID-19 and solid tumors: a multicenter retrospective cohort study.
Liu C; Li L; Song K; Zhan ZY; Yao Y; Gong H; Chen Y; Wang Q; Dong X; Xie Z; Ou CQ; Hu Q; Song Q
J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32895296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
